Skip to main content

Table 2 Demographic and clinical characteristics between enrolled patients with and without MetS, grouped by gender

From: Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients

Parameters

MetS (n = 73)

Non-MetS (n = 595)

Gender F (p -value)

Diagnosis F (p -value)

Gender × diagnosis F (p -value)

Male (n = 16)

Female (n = 57)

Male (n = 228)

Female (n = 367)

   

Age—years

31.08 ± 7.72

26.59 ± 5.55

29.10 ± 6.80

30.27 ± 7.47

2.50(0.114)

0.66 (0.419)

7.24 (< .001*)

Course of disease—years

6.70 ± 5.30

5.33 ± 3.88

5.15 ± 4.55

5.03 ± 4.91

1.16 (0.283)

1.76 (0.185)

0.80(0.371)

Onset age—years

24.37 ± 5.77

21.26 ± 4.69

23.95 ± 6.36

25.24 ± 6.51

0.96 (0.328)

3.63 (0.057)

5.59 (0.018*)

MetS dimensions

 WC—cm

86.53 ± 10.3

90.64 ± 6.52

76.74 ± 8.63

77.04 ± 7.89

3.39 (0.066)

95.45 (< .001*)

2.53 (0.112)

 FBG—mmol/L

5.87 ± 0.50

5.65 ± 0.57

5.53 ± 0.49

5.58 ± 0.46

1.42 (0.234)

8.24 (0.004*)

3.70 (0.055)

 SBP—mmHg

120.63 ± 14.82

127.46 ± 14.91

112.07 ± 11.09

111.15 ± 10.96

3.03 (0.082)

53.71(< .001*)

5.23 (0.023*)

 DBP—mmHg

84.38 ± 10.94

84.95 ± 10.89

74.43 ± 7.29

73.69 ± 7.81

0.01 (0.944)

80.06 (< .001*)

0.31 (0.580)

 TG—mmol/L

1.77 ± 0.55

1.73 ± 0.60

1.04 ± 0.51

1.00 ± 0.49

0.21 (0.646)

94.79 (< .001*)

0.00 (0.997)

 HDL-C—mmol/L

1.22 ± 0.19

1.15 ± 0.14

1.17 ± 0.26

1.19 ± 0.23

0.53 (0.467)

0.00 (0.950)

1.41 (0.236)

 TC—mmol/L

4.38 ± 0.70

4.39 ± 0.67

3.80 ± 0.69

3.77 ± 0.7

0.02 (0.8901)

33.95 (< .001*)

0.05 (0.828)

 LDL-C—mmol/L

2.57 ± 0.81

2.53 ± 0.65

2.16 ± 0.55

2.12 ± 0.56

0.19 (0.661)

23.22 (< .001*)

0.00 (0.950)

 RBC—1012/L

4.62 ± 0.30

4.78 ± 0.32

4.51 ± 0.52

4.53 ± 0.46

1.53 (0.216)

6.89 (0.009*)

1.05 (0.306)

 HGB—g/L

139.62 ± 12.57

144.96 ± 12.08

135.14 ± 18.6

134.84 ± 16.98

0.99 (0.320)

8.35 (0.004*)

1.25 (0.264)

 WBC—109/L

7.59 ± 2.28

7.86 ± 1.95

7.03 ± 2.14

6.66 ± 1.85

0.03 (0.866)

9.02 (0.003*)

1.19 (0.275)

 PLT—109/L

263.81 ± 82.21

256.58 ± 52.17

243.25 ± 58.32

238.61 ± 56.1

0.49 (0.483)

5.20 (0.023*)

0.24 (0.878)

 BUN—mmol/L

4.28 ± 1.22

4.08 ± 1.13

4.61 ± 1.79

4.48 ± 1.85

0.41 (0.524)

2.02 (0.156)

0.01 (0.908)

 CRE—mmol/L

55.56 ± 17.42

61.78 ± 18.09

58.25 ± 12.01

57.22 ± 11.51

1.99 (0.160)

0.26 (0.613)

3.85 (0.050)

 UA—mmol/L

425.4 ± 129.32

401.12 ± 83.15

417.84 ± 129.21

411.65 ± 125.79

0.64 (0.405)

0.01 (0.936)

0.25 (0.621)

 TSH—uIU/mL

1.83 ± 0.73

1.74 ± 0.70

1.71 ± 0.71

1.67 ± 0.72

0.37 (0.543)

0.75 (0.388)

0.04 (0.835)

 FT3—pmol/L

4.84 ± 0.75

4.68 ± 0.77

4.88 ± 0.67

4.86 ± 0.68

0.80 (0.372)

1.21 (0.271)

0.46 (0.498)

 FT4—pmol/L

14.73 ± 2.32

15.53 ± 3.30

17.19 ± 3.20

17.11 ± 3.05

0.63 (0.429)

19.35 (< .001*)

0.93 (0.335)

 CGI-SI

5.13 ± 0.72

5.09 ± 0.43

5.45 ± 0.61

5.36 ± 0.64

0.50 (0.482)

10.63 (0.001*)

0.09 (0.770)

 PANSS

90.69 ± 14.54

84.74 ± 11.6

89.34 ± 11.32

89.2 ± 11.24

3.29 (0.070)

0.86 (0.354)

2.99 (0.084)

  Positive factor

16.31 ± 3.24

15.18 ± 3.17

15.79 ± 3.60

16.06 ± 3.51

0.70 (0.403)

0.12 (0.727)

1.85 (0.174)

  Negative factor

29.06 ± 7.19

27.09 ± 7.14

28.61 ± 6.34

28.13 ± 5.94

1.78 (0.183)

0.10 (0.749)

0.67 (0.413)

  Excitement factor

12.44 ± 5.35

11.33 ± 4.64

12.88 ± 4.33

12.84 ± 4.41

0.77 (0.381)

2.21 (0.138)

0.66 (0.416)

  Anxiety/depression factor

14.31 ± 4.29

14.30 ± 3.97

15.28 ± 4.74

15.74 ± 4.41

0.12 (0.734)

3.30 (0.070)

0.13 (0.718)

  Cognitive factor

17.94 ± 5.78

16.53 ± 3.86

16.6 ± 4.58

16.34 ± 4.31

1.65 (0.199)

1.39 (0.240)

0.78 (0.377)

  1. WC waist circumference, FBG fasting blood glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, HDL-C high-density lipoprotein cholesterol, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, RBC red blood cell, HGB hemoglobin, WBC white blood cell, PLT platelet, BUN blood urea nitrogen, CRE blood creatinine, UA blood uric acid, TSH thyroid stimulating hormone, FT3 free triiodothyronine, FT4 free tetraiodothyronine, PANSS Positive and Negative Syndrome Scale, CGI-SI Clinical Global Impression Scale—Severity of Illness. *p < 0.05